v3.26.1
Shareholders' Equity
 3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders’ Equity
Share Repurchase Program
In July 2024, our board of directors authorized the Repurchase Program, to repurchase ordinary shares having an aggregate purchase price of $500.0 million, exclusive of any brokerage commissions. The Repurchase Program, which has no expiration date, allows us to repurchase ordinary shares from time to time by any methods and/or structures permitted by applicable law. The timing and amount of repurchases will depend on a variety of factors, including the price of our ordinary shares, alternative investment opportunities, restrictions under the Amended Credit Agreement and the indenture for our Secured Notes, corporate and regulatory requirements and market conditions. The Repurchase Program may be modified, suspended or discontinued at any time without our prior notice. During the three months ended March 31, 2026 and 2025, no shares were repurchased. As of March 31, 2026, the remaining amount authorized for repurchases under the Repurchase Program was $225.0 million, exclusive of any brokerage commissions.
Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss as of March 31, 2026 and December 31, 2025 were as follows (in millions): 
Net Unrealized
Loss From
Hedging Activities		Foreign
Currency
Translation
Adjustments		Total
Accumulated
Other
Comprehensive
Loss
Balance at December 31, 2025$(0.4)$(568.2)$(568.6)
Other comprehensive income (loss) before reclassifications0.1 (82.7)(82.6)
Amounts reclassified from accumulated other comprehensive loss0.2 — 0.2 
Other comprehensive income (loss), net0.3 (82.7)(82.4)
Balance at March 31, 2026$(0.1)$(650.9)$(651.0)
During the three months ended March 31, 2026, other comprehensive income (loss) primarily reflects foreign currency translation adjustments, primarily due to the weakening of sterling against the U.S. dollar.